Autoren: |
AGATA
KOPINIAK
Student of biology at the Wrocław University of Environmental and Life Sciences EWA RĘBACZ-MARON University of Szczecin, Department of Vertebrate Zoology and Anthropology, Institute for Research on Biodiversity, Faculty of Biology |
Schlüsselbegriffe: | otyłość czynniki środowiskowe choroby cywilizacyjne czynniki genetyczne |
Veröffentlichungsdatum der gesamten Ausgabe: | 2018 |
Seitenanzahl: | 16 (95-110) |
1. | Alharbi, K.K., Spanakis, E., Tan, K. (2007). Prevalence and functionality of paucimorphic and private |
2. | MC4R mutations in a large, unselected European British population, scanned by meltMADGE. Human |
3. | Mutation, 28 (3), 294–302. |
4. | Bartuzi, Z. (2009). Alergia na pokarmy u dorosłych w praktyce lekarskiej. Postępy Dermatologii i Alergologii, |
5. | XXVI (5), 385–387. |
6. | Begg, M., Pacher, P., Batkai, S. Osei-Hyiaman, D., Offertáler, L., Ming Mo, F., Liu, J., Kunos, G. (2005). |
7. | Evidence for novel cannabinoid receptors. Pharmacology & Therapeutics, 106, 133–145. |
8. | Benzinou, M., Chevre, J.C., Ward, K. Lecoeur, C., Dina, C., Lobbens, S., Durand, E., Delplanque, J. (2008). |
9. | Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index |
10. | in European populations. Human Molecular Genetics, 17, 1916–1921. |
11. | Białkowska, M., Szostak, W.B. (2010). Żywienie w otyłości. In: M. Grzymisławski, J. Gawęcki (eds.), |
12. | Żywienie człowieka zdrowego i chorego (pp. 332–345). Warszawa: Wydawnictwo Naukowe PWN. |
13. | Białkowska, M. (2011). Etiopatogeneza Otyłości. Postępy Nauk Medycznych, 9 (XXIV), 765–769. |
14. | Bittel, D.C., Kibiryeva, N., Sell, S.M., Strong, TV., Butler, M.G. (2007). Whole genome microarray analysis |
15. | of gene expression in Prader-Willi syndrome. American Journal of Medical Genetics. Part A, 143 (5), |
16. | 430–442. |
17. | Bose, M., Olivián, B., Laferrère, B. (2009). Stress and obesity: the role of the hypothalamic–pituitary–adrenal |
18. | axis in metabolic disease. Current Opinion in Endocrinology, Diabetes and Obesity, 16 (5), |
19. | 340–346. |
20. | Brodzicki, J. (2006). Przepuszczalność jelitowa-temat wart zainteresowania. Pediatria Współczesna. Gastroenterologia, |
21. | Hepatologia i Żywienie Dziecka, 8 (3), 188–191. |
22. | Brownell, K.D., Wadden, T.A. (1999). The LEARN Program for Weight Control. Dallas: American Health |
23. | Publishing Company. |
24. | Cassard-Doulcier, A.M., Bouillaud, F., Chagnon, M., Gelly, C., Dionne, F.T., Oppert, J.M., Bouchard, C., |
25. | Chagnon, Y., Ricquier, D. (1996). The Bcl I polymorphism of the human uncoupling protein (ucp) |
26. | gene is due to a point mutation in the 5’-flanking region. International Journal Obesity Relatet Metabolic |
27. | Disorders, 20, 278–279. |
28. | Chmielewska-Kassassir, M., Woźniak, L., Ogrodniczek, P. Wójcik, M. (2013). Rola receptorów aktywowanych |
29. | przez proliferatory peroksysomów γ (PPARγ) w otyłości i insulinooporności. Postępy Higieny |
30. | i Medycyny Doświadczalnej, 67, 1283–1299. |
31. | Clement, K., Ruiz, J., Cassard-Doulcier, A.M., Bouillaud, F., Ricquier, D., Basdevant, A., Guy-Grand, |
32. | B., Froguel, P. (1996). Additive effect of A-->G (–3826) variant of the uncoupling protein gene and |
33. | the Trp64Arg mutation of the β3-adrenergic receptor gene on weight gain in mor- bid obesity. Int. |
34. | J. Obes. Relat. Metab. Disord., 20, 1062–1066. |
35. | Deeb, S.S., Fajas, L., Nemoto, M. Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., |
36. | Auwerx, J. (1998). A Pro12Ala substitution in PPAR2: associated with decreased receptor activity, |
37. | lower body mass index and improved insulin sensitivity. Nature Genetics, 20 (3), 284–287. |
38. | Di Marzo, V., Matias, I. (2005). Endocannabinoid control of food intake and energy balance. Nature Neuroscience, |
39. | 8, 585–589. |
40. | Dubern, B., Bisbis, S., Talbaoui, H. (2007). Homozygous null mutation of the melanocortin-4 receptor and |
41. | severe early-onset obesity. Journal of Pediatrics, 150 (6), 613–617. |
42. | Erlinger, T.P., Miller, E.R., Charleston, J. Appel, L.J. (2003). Inflammation modifies the effects of a reducedfat |
43. | low-cholesterol diet on lipids results from the DASH-dodium trial. Circulation, 108, 150–154. |
44. | Farooqi, I.S., Matarese, G., Lord, G.M. (2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness, |
45. | and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. The Journal |
46. | of Clinical Investigation, 110, 1093–1103. |
47. | Farooqi, I.S., Wangensteen, T., Collins, S. Kimber, W. (2007). Clinical and molecular genetic spectrum |
48. | of congenital deficiency of the leptin receptor. The New England Journal Medicine, 356 (3), 237–247. |
49. | Florez, H., Martinez, R., Chacra, W., Strickman-Stein, N., Levis, S. (2007). Outdoor exercise reduces the |
50. | risk of hypovitaminosis D in the obese. The Journal of Steroid Biochemistry and Molecular Biology, |
51. | 3–5 (103), 679–681. |
52. | Foss, Y.J. (2009). Vitamin D deficiency is the cause of common obesity. Medical Hypotheses, 72, 314–321. |
53. | Frank, M., Szachta, P., Gałęcka, M., Ignyś, I. (2014). Alergia Pokarmowa IgG-zależna i jej znaczenie w otyłości |
54. | i cukrzycy typu 2. Forum Zaburzeń Metabolicznych, 3 (5), 108-114. |
55. | Franks, P.W., Jablonski, K.A., Delahanty, L. (2007). Diabetes Prevention Program Research Group. |
56. | The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in |
57. | obesity-related traits in the Diabetes Prevention Program. Diabetologia, 50 (12), 2451–2460. |
58. | Furet, J.P., Kong, L.C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.L., Mariat, D., Corthier, G., Doré, J., |
59. | Henegar, C., Rizkalla, S., Clément, K. (2010). Differential adaptation of human gut microbiota to |
60. | bariatric surgery-induced weight loss: links with metabolic and low grade inflammation markers. |
61. | Diabetes, 59, 3049–3057. |
62. | Gałęcka, M., Szachta, P., Bartnicka, A., Cichy, W. (2013). Alergia IgG-zależna a wybrane choroby przewodu |
63. | pokarmowego. Przegląd Gastroenterologiczny, 8 (4), 225–229. |
64. | Gangwisch, J., Malaspina, D., Boden-Albala, B., Heymsfield, S.B. (2005). Inadequate sleep as a risk factor |
65. | for obesity: Analyses of the NHANES I. Sleep, 28 (10), 1289–1296. |
66. | Harrold, J.A., Williams, G. (2003). The canna- binoid system: a role in both the homeostatic and hedonic |
67. | control of eating? British Journal of Nutrition, 90, 729–734. |
68. | Henneberg, M., Grantham, J. (2014). Obesity – a natural consequence of human evolution. Anthropological |
69. | Review, 77 (1), 1–10. |
70. | Heymsfield, S.B., Fong, T.M., Gantz, I., Erondu, N. (2006). Fat and energy partitioning: longitudinal observations |
71. | in leptin-treated adults homozygous for a Lep mutation. Obesity, 14 (2), 258–265. |
72. | Jakuszkowiak, K., Cubała, W.J. (2004). Zespół jedzenia nocnego – rozpowszechnienie, diagnoza i leczenie. |
73. | Psychiatria, 2 (1), 107–111. |
74. | Jia, J.J., Tian, Y.B., Cao, Z.H., Tao, L.L., Zhang, X., Gao, S.Z., Ge, C.R., Lin, Q.Y., Jois, M. (2010). The polymorphisms |
75. | of UCP1 genes associated with fat metabolism, obesity and diabetes. Molecular Biology |
76. | Reports, 37, 1513–1522. |
77. | Kim, K.S., Cho, D.Y., Kim, Y.J., Choi, S.M., Kim, J.Y., Shin, S.U., Yoon, Y.S. (2005). The finding of new |
78. | genetic polymorphism of UCP-1 A-1766G and its effects on body fat accumulation. Biochim. Biophys. |
79. | Acta, 1741, 149–155. |
80. | Kirkham, T.C. (2005). Endocannabinoids in the regulation of appetite and body weight. Behavioural Pharmacology, |
81. | 16, 297–313. |
82. | Kogure, A., Yoshida, T., Sakane, N., Umekawa, T., Takakura, Y., Kondo, M. (1998). Synergic effect of polymorphisms |
83. | in uncoupling protein 1 and β3-adrenergic receptor genes on weight loss in obese Japanese. |
84. | Diabetologia, 41, 1399. |
85. | Komorowski, J., Stępień, H. (2007). Rola układu endokannabinoidowego w regulacji czynności dokrewnej |
86. | i kontroli równowagi energetycznej człowieka. Postępy Higieny i Medycyny Doświadczalnej, 61, |
87. | 99–105. |
88. | Kull, M., Kallikorm, R., Lember, M. (2009). Body mass index deter- mines sunbathing habits: implications |
89. | on vitamin D levels. Internal Medicine Journal, 39, 256–258. |
90. | Ledbetter, D.H, Mascarello, J.T, Riccardi, V.M, Harper, V.D, Airhart, S.D, Strobel, R.J. (1982). Chromosome |
91. | 15 abnormalities and the Prader-Willi syndrome: a follow-up report of 40 cases. American |
92. | Journal of Human Genetics, 34 (2), 278–285. |
93. | Lee, S., Kozlov, S., Hernandez, L. Chamberlain, S.J. Brannan, C.I. Stewart, C.L. Wevrick, R. (2000). Expression |
94. | and imprinting of MAGEL2 suggest a role in Prader-Willi syndrome and the homologous |
95. | murine imprinting phenotype. Human Molecular Genetics, 9 (12), 1813–1819. |
96. | Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I. (2006). Human gut microbes associated with obesity. |
97. | Nature, 444, 1022–1023. |
98. | Lorenzo, M., Fernández-Veledo, S., Vila-Bedmar, R. et al. (2008). Insulin resistance induced by tumor |
99. | necrosis factor-alpha in myocytes and brown adipocytes. Journal of Animal Science, 86 (14 supl.), |
100. | E94–E10. |
101. | Lubrano-Berthelier, C., Dubern, B., Lacorte, J.M. (2006). Melanocortin 4 receptor mutations in a large |
102. | cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, |
103. | and lack of association with binge eating. The Journal of Clinical Endocrinology & Metabolism, |
104. | 91 (5), 1811–1818. |
105. | Major, G.C., Chaput, J.P., Ledoux, M., St-Pierre, S., Anderson, G.H., Zemel, M.B. (2008). Tremblay A. |
106. | Recent developments in calcium – related obesity research. Obesity Review, 9, 428–445. |
107. | Memisoglu, A., Hu, F.B., Hankinson, S.E. Manson, J.E., De Vivo, M., Willett, W.C., Hunter, D.J. (2003). |
108. | Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and |
109. | dietary fat intake in relation to body mass. Human Molecular Genetics, 12 (22), 2923–2929. |
110. | Męczekalski, B., Czyżyk, A., Warenik-Szymankiewicz, A. (2008). Rola genów w powstawaniu otyłości. |
111. | Współczesne poglądy, patogeneza, aspekty kliniczne. Endokrynologia. Otyłość i Zaburzenia Przemiany |
112. | Materii, 5 (1), 27–37. |
113. | Moller, D.E. (2000). Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. |
114. | Trends Endocrinology & Metabolism, 11 (6), 212–217. |
115. | Mosley, M. (2017). The Clever Guts Diet. Parenting Matters. |
116. | Muscatelli, F., Abrous, D.N., Massacrier, A. Boccaccio, I., Le Moal, M., Cau, P., Cremer, H. (2000). Disruption |
117. | of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the |
118. | human Prader-Willi syndrome. Human Molecular Genetics, 9 (20), 3101–3110. |
119. | Nguyen, S., Choi, H.K., Lustig, R.H., Chi-yuan Hsu. (2009). Sugar - Sweetened beverages, serum uric acid, |
120. | and blood pressure in adolescents. Journal Pediatrics, 154, 807–813. |
121. | Nicholls, D.G., Locke, R.M. (1984). Thermogenic mechanisms in brown fat. Physiological Reviews, 64 (1), |
122. | 1–64. |
123. | Nieto-Vazquez, I., Fernández-Veledo, S., Krämer, D.K., Vila-Bedmar, R., Garcia-Guerra, L., Lorenzo, M. |
124. | (2008). Insulin resistance associated to obesity: the link TNF-alpha. Archives of Physiology and Biochemistry, |
125. | 114 (3), 183–194. |
126. | Obesity and overweight (2018). WHO. Retrieved from: www.who.int/news-room/fact-sheets/detail/obesity- |
127. | and-overweight. |
128. | Ogińska-Bulik, N. (2007). Pułapki jedzenia. Style i Charaktery, 2, 14–16. |
129. | Oppert, J.M., Vohl, M.C., Chagnon, M., Dionne, F.T., Cassard-Doulcier, A.M., Ricquier, D., Perusse, L., |
130. | Bouchard, C. (1994). DNA polymorphism in the uncoupling protein (UCP) gene and human body fat. |
131. | Int. J. Obes. Relat. Metab. Disord., 18, 526–531. |
132. | Physical status: the Use and Interpretation of Anthropometry. Report of a WHO expert committee. WHO |
133. | Tech Rep Ser Geneva 854 (1995), 1–452. |
134. | Pietrzykowska, E., Wierusz-Wysocka, B. (2008). Psychologiczne aspekty nadwagi, otyłości i odchudzania |
135. | się. Polski Merkuriusz Lekarski, XXIV, 473–475. |
136. | Rankinen, T., Zuberi, A., Chagnon, Y.C. Weisnagel, S.J., Argyropoulos, G. Walts, B., Perusse, LB., Bouchard, |
137. | C. (2006). The human obesity gene map: The 2005 Update. Obesity, 14 (4), 529–644. |
138. | Saely, C.H., Geiger, K., Drexel, H. (2012). Brown versus white adipose tissue: a mini-review. Gerontology, |
139. | 58, 15–23. |
140. | Stice, E., Presnell, K., Shaw, H., Rohde, P. (2005). Psychological and Behavioral Risk Factors for Obesity |
141. | Onset in Adolescent Girls: A Prospective Study. Journal of Consulting and Clinical Psychology, |
142. | 73 (2), 195–202. |
143. | Stosio, M., Witkowicz, A., Kowalska, A., Karabon, L. (2016). Genetyczne uwarunkowania zaburzonej |
144. | ekspresji termogeniny (UCP1) w otyłości prowadzącej do zespołu metabolicznego. Postępy Higieny |
145. | i Medycyny Doświadczalnej, 70, 1389–1403. |
146. | Stunkard, A.J., Allison, K.C. (2003). Two forms of disordered eating in obesity: binge eating and night eating. |
147. | International Journal of Obesity, 27, 1–12. |
148. | Szymocha, M., Bryła, M., Maniecka-Bryła, I. (2009). Epidemia otyłości w XXI wieku. Zdrowie Publiczne, |
149. | 119 (2), 207–212. |
150. | Vaisse, C., Clement, K., Guy-Grand, B., Froguel, P. (1998). A frameshift mutation in human MC4R is associated |
151. | with a dominant form of obesity. Nature Genetics, 20, 113–114. |
152. | van Baak, M.A., Saris, W.H.M. (1999). Exercise and Obesity. In: P.G. Kopelman, M.J. Stock (eds.). Clinical |
153. | Obesity. Oxford: Blackwell Science. |
154. | Van Loan, M. (2009). The Role of Dairy Foods and Dietary Calcium in Weight Management. Journal of the |
155. | American College of Nutrition, 28 (1), 120–129. |
156. | Varela, M.C., Simoes-Sato, A.Y., Kim, C.A., Bertola, D.R., De Castro, C.I., Koiffmann, C.P. (2006). A new |
157. | case of interstitial 6q16.2 deletion in a patient with Prader-Willi-like phenotype and investigation |
158. | of SIM1 gene deletion in 87 patients with syndromic obesity. European Journal of Medical Genetics, |
159. | 49 (4), 298–305. |
160. | Wąsowski, M., Walicka, M., Marcinkowska-Suchowierska, E. (2012). Obesity - the condition predisposing |
161. | to vitamin D deficiency. Postępy Nauk Medycznych, 3 (XXV), 258–264. |
162. | Wąsowski, M., Walicka, M., Marcinkowska-Suchowierska, E. (2013). Otyłość-definicja, emidemiologia, |
163. | patogeneza. Postępy Nauk Medycznych, 4 (XXVI), 301–305. |
164. | Wijers, S.L., Saris, W.H., van Marken Lichtenbelt, W.D. (2009). Recent advances in adaptive thermogenesis: |
165. | potential implications for the treatment of obesity. Obesity Reviews, 10, 218–226. |
166. | Wilders-Truschnig, M., Mangge, H., Lieners, C. Gruber, H.J., Mayer, C., März, W. (2008). IgG antibodies |
167. | against food antigens are correlated with inflammation and intima media thickness in obese juveniles. |
168. | Experimental and Clinical Endocrinology & Diabetes, 116 (4), 241–245. |
169. | Wójcik, B. (2011). Brunatna tkanka tłuszczowa u dorosłego człowieka: występowanie i funkcja. Endokrynologia. |
170. | Otyłość i Zaburzenia Przemiany Materii, 7, 34–40. |
171. | Xiang, Z., Pogozheva, I.D., Sorenson, N.B. (2007). Peptide and small molecules rescue the functional |
172. | activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms. Biochemistry, |
173. | 46 (28), 8273–8287. |
174. | Yeo, G.S., Farooqi, I.S., Aminian, S., Halsall, D.J., Stanhope, R.G., O’Rahilly, S. (1998). A frameshift mutation |
175. | in MC4R associated with dominantly inherited human obesity. Nature Genetics, 20, 111–112. |
176. | Zahorska-Markiewicz, B. (2009). Zasady postępowania w otyłości. Kraków: Archi Plus. |
177. | Zawisza, E. (2010). Reakcje pokarmowe – nie mediowane IgG. Alergia, 3, 47–48. |
178. | Zemel, M.B. (2003). Role of dietary calcium and dairy products in modulating adiposity. Lipids, 38, 139– |
179. | 146. |
180. | Zemel, M.B. (2005). The role of dairy foods in weight managements. Journal of the American College |
181. | of Nutrition, 24, 5375–5465. |
182. | Zgliczyński, W.S. (2017). Nadwaga i otyłość w Polsce. Infos, 4 (227). |
183. | Żak-Gołąb, A., Olszanecka-Glinianowicz, M., Kocełak, P. (2014). Rola mikroflory jelitowej w patogenezie |
184. | otyłości. Postępy Higieny i Medycyny Doświadczalnej, 68, 84–90. |